This will play a video. - woman swimming

Transcatheter Aortic Heart Valve Replacement

From a design built on a proven platform1, the EVOLUT™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.


Built upon the proven Evolut platform, the Evolut PRO+ system offers the lowest delivery profile for 23-29 mm valves, excellent hemodynamics, the broadest annulus range,* and advanced sealing with an external tissue wrap.

Beauty shot of the Evolut Pro+ system heart valve


evolut first predictibility brochure

Leading Hemodynamics

Designed for large EOAs, low gradients, and minimal patient prosthesis mismatch, the Evolut TAV allows your patient to return to activity faster.

Evolut Pro 29mm



Data on file (>20 clinical trials with over 20000 patients enrolled).


Broadest annulus range based on CT derived diameters.

Popma JJ. SURTAVI: Two Year Complete Results from a Randomized Trial of a Self-expanding Transcatheter Heart Valve vs. Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk. Presented at TCT 2018; San Diego, CA.